Abstract
Since the initial description of the arteriovenous (AV) fistula, autogenous access has been the procedure of choice for chronic hemodialysis. Recently established National Kidney Foundation Dialysis Outcome and Quality Initiative guidelines have validated the superiority of arteriovenous fistulas over AV grafts but have also addressed the fact that a significant percentage of the growing dialysis population does not have veins suitable for primary AV fistulas. Recent advances in forearm, upper arm, and femoral venous transpositions have facilitated the performance of increased numbers of autogenous access procedures. Nevertheless, substantial numbers of patients on chronic hemodialysis require prosthetic AV grafts. Since early reports describing hemodialysis access using expanded polytetrafluoroethylene, surgical results with prosthetic graft materials have remained suboptimal. Modifications in polytetrafluoroethylene grafts and the recent development of alternative graft materials for hemodialysis access have yielded encouraging early results in efforts to improve patency of AV grafts. We will review currently available graft materials and recent developments in an ongoing effort to improve the results with prosthetic and biologic hemodialysis access conduits.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 19-24 |
| Number of pages | 6 |
| Journal | Seminars in Vascular Surgery |
| Volume | 17 |
| Issue number | 1 |
| DOIs | |
| State | Published - Mar 2004 |
Fingerprint
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Alternative Graft Materials for Hemodialysis Access. / Scher, Larry A.; Katzman, Howard E.
In: Seminars in Vascular Surgery, Vol. 17, No. 1, 03.2004, p. 19-24.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Alternative Graft Materials for Hemodialysis Access
AU - Scher, Larry A.
AU - Katzman, Howard E.
PY - 2004/3
Y1 - 2004/3
N2 - Since the initial description of the arteriovenous (AV) fistula, autogenous access has been the procedure of choice for chronic hemodialysis. Recently established National Kidney Foundation Dialysis Outcome and Quality Initiative guidelines have validated the superiority of arteriovenous fistulas over AV grafts but have also addressed the fact that a significant percentage of the growing dialysis population does not have veins suitable for primary AV fistulas. Recent advances in forearm, upper arm, and femoral venous transpositions have facilitated the performance of increased numbers of autogenous access procedures. Nevertheless, substantial numbers of patients on chronic hemodialysis require prosthetic AV grafts. Since early reports describing hemodialysis access using expanded polytetrafluoroethylene, surgical results with prosthetic graft materials have remained suboptimal. Modifications in polytetrafluoroethylene grafts and the recent development of alternative graft materials for hemodialysis access have yielded encouraging early results in efforts to improve patency of AV grafts. We will review currently available graft materials and recent developments in an ongoing effort to improve the results with prosthetic and biologic hemodialysis access conduits.
AB - Since the initial description of the arteriovenous (AV) fistula, autogenous access has been the procedure of choice for chronic hemodialysis. Recently established National Kidney Foundation Dialysis Outcome and Quality Initiative guidelines have validated the superiority of arteriovenous fistulas over AV grafts but have also addressed the fact that a significant percentage of the growing dialysis population does not have veins suitable for primary AV fistulas. Recent advances in forearm, upper arm, and femoral venous transpositions have facilitated the performance of increased numbers of autogenous access procedures. Nevertheless, substantial numbers of patients on chronic hemodialysis require prosthetic AV grafts. Since early reports describing hemodialysis access using expanded polytetrafluoroethylene, surgical results with prosthetic graft materials have remained suboptimal. Modifications in polytetrafluoroethylene grafts and the recent development of alternative graft materials for hemodialysis access have yielded encouraging early results in efforts to improve patency of AV grafts. We will review currently available graft materials and recent developments in an ongoing effort to improve the results with prosthetic and biologic hemodialysis access conduits.
UR - http://www.scopus.com/inward/record.url?scp=1542636142&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1542636142&partnerID=8YFLogxK
U2 - 10.1053/j.semvascsurg.2003.11.007
DO - 10.1053/j.semvascsurg.2003.11.007
M3 - Article
C2 - 15011175
AN - SCOPUS:1542636142
VL - 17
SP - 19
EP - 24
JO - Seminars in Vascular Surgery
JF - Seminars in Vascular Surgery
SN - 0895-7967
IS - 1
ER -